Use of cardiovascular and antidiabetic drugs before and after starting with clozapine versus other antipsychotic drugs:a Dutch database study

Reports of decreased mortality among patients with schizophrenia who use clozapine may be biased if clozapine is prescribed to relatively healthy patients and if intensive monitoring during its use prevents (under-treatment of) somatic disorder. We aimed to assess whether there is a difference in: (1) somatic comorbidity between patients who start with clozapine and those who start with other antipsychotics and (2) prescribed somatic medication, between patients using clozapine and those using olanzapine. Cohort study based on insurance claims (2010-2015). After selecting new users of antipsyc... Mehr ...

Verfasser: van der Zalm, Yvonne
Termorshuizen, Fabian
Sommer, Iris E.
Selten, Jean-Paul
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: van der Zalm , Y , Termorshuizen , F , Sommer , I E & Selten , J-P 2020 , ' Use of cardiovascular and antidiabetic drugs before and after starting with clozapine versus other antipsychotic drugs : a Dutch database study ' , INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol. 35 , no. 1 , pp. 36-41 . https://doi.org/10.1097/YIC.0000000000000292
Schlagwörter: clozapine / epidemiology / outpatients / schizophrenia / 2ND-GENERATION ANTIPSYCHOTICS / MORTALITY / SAFETY / TOLERABILITY / EFFICACY
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29027978
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/690e22a0-fe8d-408b-82ff-0c1f2983dbff